Data Foundry

Drug recalls 2013

Betamethasone Acetate and Betamethasone Sodium Injection — Class II drug recall D-343-2013

Terminated recall by FVS Holdings, Inc. dba. Green Valley Drugs, reported 2013-05-22, distributed nationwide. Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compoundi

Recall numberD-343-2013
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmFVS Holdings, Inc. dba. Green Valley Drugs, Henderson, NV, United States
Recall initiated2013-04-10
Classified2013-05-16
Reported by FDA2013-05-22
Terminated2014-03-21
DistributedNationwide (US)
Quantity4,368 vials
Reason classessterility
Lot numbers20130114-A, 20130123-B, 20130124-A, 20130212-A, 20130319-M, 20130321-B
Expiration dates2013-04-14, 2013-04-23, 2013-04-24, 2013-05-12, 2013-06-19, 2013-06-21

Product

Betamethasone Acetate and Betamethasone Sodium Injection, all strengths and all presentations including 6 mg/mL preservative free, 2 ml; 106 mg/mL 10 mL, and 6 mg/mL 5 mL, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV 89014.

Reason for recall

Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-343-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.